Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

Abstract

In clinical application of gene therapy for prostate cancer, these findings provide a rationale for focusing on strategies that can circumvent sole reliance on class I MHC-mediated tumor cell recognition by CTL.